Counterfeit prescription drugs sales are expected to reach $75 billion by the end of the decade, nearly doubling current levels and outpacing the annual growth rate of legitimate pharmaceutical sales, according to a new study. Sales of counterfeits are estimated to grow 13 percent annually through 2010, compared to 7.5 percent estimated annual growth for global pharmaceutical commerce, says the report from the Center for Medicines in the Public Interest (CMPI), which is part of Pacific Research Institute, a free-market think tank. CMPI based its projections on current estimates of counterfeits from the FDA and World Health Organization. Global pharmaceutical sales are expected to grow to $530 billion by 2010, CMPI said.
展开▼
